September 1, 2021 — Sun Nuclear Corporation announced that as part of the ESTRO 2021 Congress, held August 27 – 31 in Madrid, Spain, and streaming online, the company hosted well-published clinicians in its booth and at a satellite symposium. Featured in the ESTRO scientific program, three members of the Sun Nuclear SunCHECK Platform Customer Advisory Board presented on breakthrough findings from their use of SunCHECK software for independent, automated Machine QA and Patient QA, featuring in-vivo dosimetry.
A main interest among the SunCHECK Customer Advisory Board is implementing in-vivo dosimetry with SunCHECK software to efficiently uncover errors during the radiation therapy treatment course. At GZA Ziekenhuizen - Iridium Kankernetwerk (Belgium), Evy Bossuyt, M.S., has been instrumental in implementing in-vivo dosimetry with SunCHECK Patient, and using the insights to catch and correct errors for improved treatment protocols. Her abstract (SP-0028 Large scale clinical implementation of in vivo dosimetry - What value does it bring?) reviews an analysis of 7,000 patients from 2019 and 2020. The work details a year-over-year decrease in overall failed treatment fractions and highlights how data-driven insights from SunCHECK software informed corrective actions taken to achieve these quality improvements. Bossuyt presented as part of an ESTRO Symposium, Clinical Implementation of In-Vivo Dosimetry, and in the Sun Nuclear ESTRO booth.
The Sun Nuclear Lunch Symposium, Innovations in Patient Safety & QA, was held on Sunday, August 29, live in the ESTRO Exhibit Hall Rooms N107+108 and streamed for virtual attendees. During the Symposium, Greg Martin, M.Sc., of Clatterbridge Cancer Centre (England), presented on his department’s experience with SunCHECK Machine for automated Daily, Monthly and Annual QA. His study (PO-1720: SunCHECK Machine, an automated QA software solution: A centre’s 5-year experience evaluation) reviews the Clatterbridge Medical Physics team’s experience with SunCHECK Machine, including initial viability, sensitivity testing, commissioning, long-term use and significant time-savings realized across nine linear accelerators – per system, per year.
Nuria Jornet, Ph.D., a medical physicist with Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) and member of the SunCHECK Customer Advisory Board, also presented her department’s experience with SunCHECK Platform during Sun Nuclear’s Lunch Symposium. Jornet is a former Chair of the Physics Committee for ESTRO, and during that time, was an integral part of a task group created to influence wider adoption of in-vivo dosimetry. An abstract that builds on the initial work of this task group was presented as part of the ESTRO Symposium, Clinical Implementation of In-Vivo Dosimetry.
“We’ve built and continue to enhance the independent SunCHECK Platform to help radiotherapy teams standardize, streamline and automate their QA,” noted Andy Fuller, Director of Product Management, SunCHECK. “It has been truly inspiring to see how members of the SunCHECK Customer Advisory Board continue to shape the platform’s capabilities to allow their department to reach their optimal clinical goals, and share their findings and best practices for the benefit of other departments.”
For more information: www.sunnuclear.com/estro-2021
August 09, 2024 
